lobbying_activities: 2597881

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2597881	fd4a8886-3e6e-4359-bffd-fa337a0f7928	Q1	SUMMIT PUBLIC AFFAIRS	401105467	VANDA PHARMACEUTICALS INC.	2021	first_quarter	PHA	Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. COVID-19 clinical trials. H.R. 1319, American Rescue Plan Act of 2021.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2021-04-16T13:47:28.867000-04:00